276 related articles for article (PubMed ID: 30362859)
1. Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells.
Yi C; Li G; Ivanov DN; Wang Z; Velasco MX; Hernández G; Kaundal S; Villarreal J; Gupta YK; Qiao M; Hubert CG; Hart MJ; Penalva LOF
RNA Biol; 2018; 15(11):1420-1432. PubMed ID: 30362859
[TBL] [Abstract][Full Text] [Related]
2. Musashi1 enhances chemotherapy resistance of pediatric glioblastoma cells in vitro.
Pötschke R; Gielen G; Pietsch T; Kramm C; Klusmann JH; Hüttelmaier S; Kühnöl CD
Pediatr Res; 2020 Mar; 87(4):669-676. PubMed ID: 31756732
[TBL] [Abstract][Full Text] [Related]
3. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
[TBL] [Abstract][Full Text] [Related]
4. The oncogenic RNA-binding protein Musashi1 is regulated by HuR via mRNA translation and stability in glioblastoma cells.
Vo DT; Abdelmohsen K; Martindale JL; Qiao M; Tominaga K; Burton TL; Gelfond JA; Brenner AJ; Patel V; Trageser D; Scheffler B; Gorospe M; Penalva LO
Mol Cancer Res; 2012 Jan; 10(1):143-55. PubMed ID: 22258704
[TBL] [Abstract][Full Text] [Related]
5. Musashi-1 Enhances Glioblastoma Migration by Promoting ICAM1 Translation.
Lin JC; Tsai JT; Chao TY; Ma HI; Liu WH
Neoplasia; 2019 May; 21(5):459-468. PubMed ID: 30959276
[TBL] [Abstract][Full Text] [Related]
6. The RNA-Binding Protein Musashi1 Regulates a Network of Cell Cycle Genes in Group 4 Medulloblastoma.
Baroni M; Guardia GDA; Lei X; Kosti A; Qiao M; Landry T; Mau K; Galante PAF; Penalva LOF
Cells; 2021 Dec; 11(1):. PubMed ID: 35011618
[TBL] [Abstract][Full Text] [Related]
7. Antagonism between the RNA-binding protein Musashi1 and miR-137 and its potential impact on neurogenesis and glioblastoma development.
Velasco MX; Kosti A; Guardia GDA; Santos MC; Tegge A; Qiao M; Correa BRS; Hernández G; Kokovay E; Galante PAF; Penalva LOF
RNA; 2019 Jul; 25(7):768-782. PubMed ID: 31004009
[TBL] [Abstract][Full Text] [Related]
8. RNA-Binding Protein Musashi1 Is a Central Regulator of Adhesion Pathways in Glioblastoma.
Uren PJ; Vo DT; de Araujo PR; Pötschke R; Burns SC; Bahrami-Samani E; Qiao M; de Sousa Abreu R; Nakaya HI; Correa BR; Kühnöl C; Ule J; Martindale JL; Abdelmohsen K; Gorospe M; Smith AD; Penalva LO
Mol Cell Biol; 2015 Sep; 35(17):2965-78. PubMed ID: 26100017
[TBL] [Abstract][Full Text] [Related]
9. The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs.
Vo DT; Qiao M; Smith AD; Burns SC; Brenner AJ; Penalva LO
RNA Biol; 2011; 8(5):817-28. PubMed ID: 21881409
[TBL] [Abstract][Full Text] [Related]
10. Musashi1 Promotes Non-Small Cell Lung Carcinoma Malignancy and Chemoresistance via Activating the Akt Signaling Pathway.
Lang Y; Kong X; He C; Wang F; Liu B; Zhang S; Ning J; Zhu K; Xu S
Cell Physiol Biochem; 2017; 44(2):455-466. PubMed ID: 29141252
[TBL] [Abstract][Full Text] [Related]
11. Intracellular functions of RNA-binding protein, Musashi1, in stem and cancer cells.
Forouzanfar M; Lachinani L; Dormiani K; Nasr-Esfahani MH; Gure AO; Ghaedi K
Stem Cell Res Ther; 2020 May; 11(1):193. PubMed ID: 32448364
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of Msi1 suppresses the growth of human colon cancer by targeting p21cip1.
Gao C; Han C; Yu Q; Guan Y; Li N; Zhou J; Tian Y; Zhang Y
Int J Oncol; 2015 Feb; 46(2):732-40. PubMed ID: 25394506
[TBL] [Abstract][Full Text] [Related]
13. RNA-binding protein Musashi1 modulates glioma cell growth through the post-transcriptional regulation of Notch and PI3 kinase/Akt signaling pathways.
Muto J; Imai T; Ogawa D; Nishimoto Y; Okada Y; Mabuchi Y; Kawase T; Iwanami A; Mischel PS; Saya H; Yoshida K; Matsuzaki Y; Okano H
PLoS One; 2012; 7(3):e33431. PubMed ID: 22428049
[TBL] [Abstract][Full Text] [Related]
14. Musashi-1 regulates AKT-derived IL-6 autocrinal/paracrinal malignancy and chemoresistance in glioblastoma.
Chen HY; Lin LT; Wang ML; Lee SH; Tsai ML; Tsai CC; Liu WH; Chen TC; Yang YP; Lee YY; Chang YL; Huang PI; Chen YW; Lo WL; Chiou SH; Chen MT
Oncotarget; 2016 Jul; 7(27):42485-42501. PubMed ID: 27285760
[TBL] [Abstract][Full Text] [Related]
15. Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma.
Qin G; Lian J; Yue D; Chen X; Nan S; Qi Y; Li B; Cui G; Li X; Zhao S; Zhang Y
Oncol Rep; 2017 Sep; 38(3):1724-1732. PubMed ID: 28713964
[TBL] [Abstract][Full Text] [Related]
16. Musashi-1 Enhances Glioblastoma Cell Migration and Cytoskeletal Dynamics through Translational Inhibition of Tensin3.
Chen HY; Lin LT; Wang ML; Laurent B; Hsu CH; Pan CM; Jiang WR; Chen PY; Ma HI; Chen YW; Huang PI; Chiou A; Chiou SH
Sci Rep; 2017 Aug; 7(1):8710. PubMed ID: 28821879
[TBL] [Abstract][Full Text] [Related]
17. The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis.
Vo DT; Subramaniam D; Remke M; Burton TL; Uren PJ; Gelfond JA; de Sousa Abreu R; Burns SC; Qiao M; Suresh U; Korshunov A; Dubuc AM; Northcott PA; Smith AD; Pfister SM; Taylor MD; Janga SC; Anant S; Vogel C; Penalva LO
Am J Pathol; 2012 Nov; 181(5):1762-72. PubMed ID: 22985791
[TBL] [Abstract][Full Text] [Related]
18. Musashi1 Impacts Radio-Resistance in Glioblastoma by Controlling DNA-Protein Kinase Catalytic Subunit.
de Araujo PR; Gorthi A; da Silva AE; Tonapi SS; Vo DT; Burns SC; Qiao M; Uren PJ; Yuan ZM; Bishop AJ; Penalva LO
Am J Pathol; 2016 Sep; 186(9):2271-8. PubMed ID: 27470713
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of MUSASHI1 in epithelial breast cancer cells is due to down regulation of miR-125b.
Forouzanfar M; Lachinani L; Dormiani K; Nasr-Esfahani MH; Ghaedi K
BMC Mol Cell Biol; 2021 Feb; 22(1):10. PubMed ID: 33541259
[TBL] [Abstract][Full Text] [Related]
20. Genomic analyses of musashi1 downstream targets show a strong association with cancer-related processes.
de Sousa Abreu R; Sanchez-Diaz PC; Vogel C; Burns SC; Ko D; Burton TL; Vo DT; Chennasamudaram S; Le SY; Shapiro BA; Penalva LO
J Biol Chem; 2009 May; 284(18):12125-35. PubMed ID: 19258308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
